Fundraising Fox
🦊/Companies
Sign in

InflaRx

Jena, DE · 2 known investors

Find your way into InflaRx

InflaRx is a biopharmaceutical company developing anti-C5a and anti-C5aR complement inhibitors targeting the complement activation factor C5a and its receptor. Its lead product, GOHIBIC (vilobelimab), received a U.S. FDA Emergency Use Authorization for treating COVID-19 in certain hospitalized adults.

BiotechHealthtech

Investors · 2

Bain Capital Life SciencesBoston
RA CapitalBoston

Funding

SEC filings, press & company announcements

$150M disclosed across 1 round · 2026

Source: company announcements and press reports — follow each round's link for the claim.

In the news

InflaRx at H.C. Wainwright conference: renal pivot takes center stage By Investing.cominvesting.com · Sep 2026InflaRx to Present at Two Key Investor Conferences in September — InflaRx N.V. | BriefGlancebriefglance.com · Aug 2026InflaRx Announces Participation in September Investor Conferences | The Manila Timesmanilatimes.net · Aug 2026InflaRx Raises $150M in Share Offering to Fuel Pipeline Growth — InflaRx N.V. | BriefGlancebriefglance.com · May 2026InflaRx (NASDAQ: IFRX) raises $150M via 75M-share offering to fund izicopanstocktitan.net · May 2026InflaRx Raises $150 Million in Underwritten Share Offering Filed in Early May 2026 - TipRanks.comtipranks.com · May 2026

Frequently asked questions

What does InflaRx do?
InflaRx is a biopharmaceutical company developing anti-C5a and anti-C5aR complement inhibitors targeting the complement activation factor C5a and its receptor. Its lead product, GOHIBIC (vilobelimab), received a U.S. FDA Emergency Use Authorization for treating COVID-19 in certain hospitalized adults.
Who are InflaRx's investors?
InflaRx's investors include Bain Capital Life Sciences, RA Capital.
How much funding has InflaRx raised?
InflaRx has disclosed $150M raised across 1 round.
Where is InflaRx headquartered?
InflaRx is headquartered in Jena, DE.